The use of antithrombotics in patients presenting with stroke and atrial fibrillation

References

• AdamsHPJrBendixenBHKappelleJClassification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trialStroke19932435417678184
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation InvestigatorsRisk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trialsAm Intern Med1994154144957
   Web of Science ®Google Scholar
• BungardTJGhaliWATeoKTWhy do patients with atrial fibrillation not receive warfarin?Am Intern Med2000160416
   Web of Science ®Google Scholar
• DiMarcoJPFlakerGWaldoALFactors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) StudyAm Heart J2005149650615990748
   PubMed Web of Science ®Google Scholar
• [EAFT] European Atrial Fibrillation Trial Study GroupSecondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor strokeLancet19933421255627901582
   PubMed Web of Science ®Google Scholar
• EvansAPerezIYuGSecondary stroke prevention in atrial fibrillation: lessons from clinical practiceStroke20003221061110978038
   PubMed Web of Science ®Google Scholar
• EvansAPerezIYuGShould stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillationStroke20013228283211739981
   PubMed Web of Science ®Google Scholar
• GageBFBoechlerMDoggetteALAdverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillationStroke200031822710753982
   PubMed Web of Science ®Google Scholar
• GageBFvan WalravenCPearceLSelecting patient with atrial fibrillation for anticoagulation. Stroke risk stratification in patients taking aspirinCirculation200411022879215477396
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannenWValidation of clinical classification schemes for predicting stroke. Researchers from the National registry of atrial fibrillationJAMA200128528647011401607
   PubMed Web of Science ®Google Scholar
• GardinerCWilliamsKMackieIJPatient self-testing is a reliable and acceptable alternative to laboratory INR monitoringBrit J Hematology20041282427
   Web of Science ®Google Scholar
• GoASHylekEMChangYAnticoagulation therapy for stroke prevention in atrial fibrillation. How well do randomized trials translate into clinical practice?JAMA200329026859214645310
   PubMed Web of Science ®Google Scholar
• GullovALKoefoedBGPetersenPFixed mini dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation; 2nd Copenhagen Atrial Fibrillation, Aspirin and Anticoagulation StudyArch Intern Med19981581513219679792
   PubMed Web of Science ®Google Scholar
• HartRGHalperinJLAtrial fibrillation and thromboembolism: a decade of progress in stroke preventionAm Intern Med199913168895
   Web of Science ®Google Scholar
• HartRGPearceLAMcBrideRFactors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trialsStroke19993012232910356104
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAMillerVJCardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the Stroke Prevention in Atrial Fibrillation StudiesCerebrovasc Dis200010394310629345
   PubMed Web of Science ®Google Scholar
• HatanoSExperience from a multicenter stroke register: a preliminary reportBull WHO197654541531088404
   PubMed Web of Science ®Google Scholar
• HylekEMGoASChangYEffect of intensity of all anticoagulation on stroke severity and mortality in atrial fibrillationN Engl J Med200334910192612968085
   PubMed Web of Science ®Google Scholar
• International Statistical Classification of DiseasesRelated health problems2000 10th Review, Australian modification. Vol.1–5. Copyright of Commonwealth of Australia
   Google Scholar
• IqbalMBTanejaAKLipGYHRecent developments in atrial fibrillationBMJ20053302384315677659
   PubMed Web of Science ®Google Scholar
• JacksonSLPetersonGMVialJupeDMLImproving the outcomes of anticoagulation: An evaluation of home follow-up of warfarin initiationJ Int Med200425613744
   PubMed Web of Science ®Google Scholar
• KoudstraalPJAnticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacksCochrane Database Syst Rev 22000CD000187
   Google Scholar
• LagunaPMartinAdel ArcoCRisk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 StudyAnn Emerg Med20044431115226703
   PubMed Web of Science ®Google Scholar
• LaupacisAAlbersGDalenJAntithrombotic therapy in atrial fibrillationChest1998114suppl5795895
   Google Scholar
• LipGYHBoosCJAntithrombotic treatment in atrial fibrillationHeart2006921556116159980
   PubMed Web of Science ®Google Scholar
• MillerVTRothrockJFPearceLAIschemic stroke in patients with atrial fibrillation. Effect of aspirin according to stroke mechanismNeurology1993433268423907
   PubMed Web of Science ®Google Scholar
• MorocuttiCAmabileGFattappostaFIndobufen versus warfarin in the secondary prevention of major vascular events in non-rheumatic atrial fibrillationStroke1997281015219158644
   PubMed Web of Science ®Google Scholar
• MurrayEFitzmauriceDMcCahonDTraining for patients in a randomized control trial of self management of warfarin treatmentBMJ2004328437814976099
   PubMed Web of Science ®Google Scholar
• Perez-GomezFAlegriaEBerjŏnJComparative of antiplatelet, anticoagulant, or combined therapy in patients with valvular and non valvular atrial fibrillationJ Am Coll Cardiol20044415576615489085
   PubMed Web of Science ®Google Scholar
• PetersenPBoysenGGodtfredsenJPlacebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The copenhagen AFASAK studyLancet1989i17592563096
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation III InvestigatorsAdjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrilliationLancet199634863388782752
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation InvestigatorsThe stroke preventions in atrial fibrillation study: final resultsCirculation199184527391860198
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation InvestigatorsBleeding during anti-thrombotic therapy in patients with atrial fibrillationArch Intern Med1996156409168607726
   PubMedGoogle Scholar
• SudlowMThomsonRThwaitesBPrevalence of atrial fibrillation and eligibility for anticoagulants in the communityLancet19983521167719777832
   PubMed Web of Science ®Google Scholar
• TaylorFCCohenHEbrahimSSystemic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillationBMJ2001322321611159653
   PubMed Web of Science ®Google Scholar
• TennantAGeddesJMChamberlainMAThe Barthel Index an ordinal score or interval level measureClin Rehab1996103018
   Google Scholar
• WangTKMassaroJMLevyDA risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the communityJAMA200329010495612941677
   PubMed Web of Science ®Google Scholar